- Home
- Labeler Index
- Mylan Specialty L.p.
- 49502-393
- NDC Crossover: 49502-393 Insulin Glargine
NDC Crossover 49502-393 Insulin Glargine
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 49502-393 Insulin Glargine a human prescription drug with other products crossover matching the same product name (Insulin Glargine) or generic name (Insulin Glargine-yfgn), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 49502-250 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
| 49502-251 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
| 49502-394 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
| 83257-011 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
| 83257-012 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
| 83257-014 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
| 83257-015 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |